Clinical Trial Suggests New Rectal Cancer Treatment Can Avoid Major Surgery

A clinical trial, coordinated by the University of Birmingham, indicates a new chemoradiotherapy approach for earlier-stage rectal cancer could allow four in five patients to avoid major surgery. Published in The Lancet Oncology, the findings suggest this method reduces severe side effects associated with traditional radical surgery, potentially becoming a new standard treatment.